This study, with its results presented at the ACC.26 conference, marks the first randomized, placebo-controlled trial ever conducted for this specific procedure, a context where maintaining blinding is notably challenging.
The SMART-DECISION study, a significant research initiative conducted in South Korea, investigated the feasibility of discontinuing beta-blocker therapy in a specific patient population. Specifically, the research focused on individuals who had experienced a myocardial infarction (heart attack)
The significant findings from the Scout-HCM study reveal the efficacy of mavacamten in addressing left ventricular outflow tract obstruction in adolescent patients with hypertrophic cardiomyopathy.
This research, presented at ACC.26, investigated the efficacy of spironolactone compared to placebo in an elderly patient population diagnosed with heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction.
The pivotal research study was presented at the annual meeting of the American College of Cardiology (ACC.26) and concurrently published in the esteemed New England Journal of Medicine.
A forthcoming study, scheduled for presentation at ACC.26, has investigated the association between hours spent in front of screens, physical activity levels, and key markers of cardiovascular risk.
A holistic approach to well-being, integrating healthy habits related to sleep, physical activity, and nutrition, proves fundamental for heart health. Even small daily improvements in these areas can add up, creating a significant impact in preventing cardiovascular diseases. Drastic changes ar
The results of the pragmatic randomized CLOSURE-AF trial are now available.